Product
Leritrelvir
3 clinical trials
3 indications
Indication
Kidney ImpairmentIndication
Drug-drug interactionsIndication
ElderClinical trial
A Phase I Single Dose, Non-Randomised, Open-Label, Parallel Group Study to Investigate the Effect of Severe Kidney Impairment on the Pharmacokinetics, Safety and Tolerability of Leritrelvir(RAY1216)Status: Completed, Estimated PCD: 2023-12-12
Clinical trial
A Phase I Single Dose, Non-Randomised, Open-Label, Parallel Group Study to Investigate Pharmacokinetics, Safety and Tolerability of RAY1216 in Elder ParticipantsStatus: Completed, Estimated PCD: 2023-09-20
Clinical trial
A Open-Label, Two-sequence Phase I Drug-drug Interaction Clinical Study to Investigate the Pharmacokinetics of Leritrelvir With Midazolam, Omeprazole, Rosuvastatin, Verapamil, and Rifampin in Healthy ParticipantsStatus: Completed, Estimated PCD: 2023-11-01